In a new video interview, Brendan Everett, MD, FACC, and James L. Januzzi Jr., MD, FACC, discuss key points to remember from the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. The Pathway, which is endorsed by the American Diabetes Association and published in the Journal of the American College of Cardiology, addresses the changing paradigm in how cardiovascular specialists should approach care of type 2 diabetes patients. Watch the video. Visit the Diabetes and Cardiometabolic Disease Clinical Topic Collection on ACC.org for the latest news and resources related to diabetes.